Expression of adrenomedullin, a hypotensive peptide, in the trophoblast giant cells at the embryo implantation site in mouse

Shinichi Yotsumoto, Tokihiko Shimada, Chang Yi Cui, Hiroshi Nakashima, Hiroyuki Fujiwara, Minoru Ko

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Adrenomedullin (AM) is a newly discovered hypotensive peptide which is believed to play an important role for blood pressure control in the adult. Although it has been well established that a major production site of AM is vascular endothelial cells, we now show that AM is most highly expressed in trophoblast giant cells, which are derived from the conceptus and are directly in contact with maternal tissues at the implantation site. Northern blot and in situ hybridization analyses show that the AM mRNA begins to be detected just after implantation and its level peaks at 9.5 days postconception (d.p.c.) in those cells. Expression then falls dramatically after 10.5 d.p.c., coincident with the completion of the mature chorioallantoic placenta. Immunohistochemical analyses show that the AM peptide is secreted from the trophoblast giant cells into the surrounding tissues, i.e., embryo, decidua, and maternal circulation. In contrast, the expression of an AM receptor was not detected by Northern blot analyses in either embryo or trophoblast giant cells at 7 d.p.c., when the AM gene is most highly expressed in the trophoblast giant cells. This suggests that the AM produced and secreted from the embryo's trophoblast giant cells acts on the maternal tissues rather than on the embryonic tissues. Based on these results, we propose that the high production of AM may be the mechanism by which the embryos survive at the early postimplantation period by pooling maternal blood in the implantation site in order to secure nutrition and oxygen before the establishment of efficient embryo-maternal circulation through the mature placenta.

Original languageEnglish
Pages (from-to)264-275
Number of pages12
JournalDevelopmental Biology
Volume203
Issue number2
DOIs
Publication statusPublished - 1998 Nov 15
Externally publishedYes

Fingerprint

Adrenomedullin
Trophoblasts
Giant Cells
Peptides
Embryonic Structures
Mothers
Northern Blotting
Placenta
Adrenomedullin Receptors
Decidua
In Situ Hybridization
Endothelial Cells
Oxygen
Blood Pressure
Messenger RNA

Keywords

  • Adrenomedullin
  • Gene expression
  • Implantation
  • Mouse
  • Trophoblast giant cells

ASJC Scopus subject areas

  • Developmental Biology

Cite this

Expression of adrenomedullin, a hypotensive peptide, in the trophoblast giant cells at the embryo implantation site in mouse. / Yotsumoto, Shinichi; Shimada, Tokihiko; Cui, Chang Yi; Nakashima, Hiroshi; Fujiwara, Hiroyuki; Ko, Minoru.

In: Developmental Biology, Vol. 203, No. 2, 15.11.1998, p. 264-275.

Research output: Contribution to journalArticle

Yotsumoto, Shinichi ; Shimada, Tokihiko ; Cui, Chang Yi ; Nakashima, Hiroshi ; Fujiwara, Hiroyuki ; Ko, Minoru. / Expression of adrenomedullin, a hypotensive peptide, in the trophoblast giant cells at the embryo implantation site in mouse. In: Developmental Biology. 1998 ; Vol. 203, No. 2. pp. 264-275.
@article{4f68cef2fbfe492d80cfdb243d03ef08,
title = "Expression of adrenomedullin, a hypotensive peptide, in the trophoblast giant cells at the embryo implantation site in mouse",
abstract = "Adrenomedullin (AM) is a newly discovered hypotensive peptide which is believed to play an important role for blood pressure control in the adult. Although it has been well established that a major production site of AM is vascular endothelial cells, we now show that AM is most highly expressed in trophoblast giant cells, which are derived from the conceptus and are directly in contact with maternal tissues at the implantation site. Northern blot and in situ hybridization analyses show that the AM mRNA begins to be detected just after implantation and its level peaks at 9.5 days postconception (d.p.c.) in those cells. Expression then falls dramatically after 10.5 d.p.c., coincident with the completion of the mature chorioallantoic placenta. Immunohistochemical analyses show that the AM peptide is secreted from the trophoblast giant cells into the surrounding tissues, i.e., embryo, decidua, and maternal circulation. In contrast, the expression of an AM receptor was not detected by Northern blot analyses in either embryo or trophoblast giant cells at 7 d.p.c., when the AM gene is most highly expressed in the trophoblast giant cells. This suggests that the AM produced and secreted from the embryo's trophoblast giant cells acts on the maternal tissues rather than on the embryonic tissues. Based on these results, we propose that the high production of AM may be the mechanism by which the embryos survive at the early postimplantation period by pooling maternal blood in the implantation site in order to secure nutrition and oxygen before the establishment of efficient embryo-maternal circulation through the mature placenta.",
keywords = "Adrenomedullin, Gene expression, Implantation, Mouse, Trophoblast giant cells",
author = "Shinichi Yotsumoto and Tokihiko Shimada and Cui, {Chang Yi} and Hiroshi Nakashima and Hiroyuki Fujiwara and Minoru Ko",
year = "1998",
month = "11",
day = "15",
doi = "10.1006/dbio.1998.9073",
language = "English",
volume = "203",
pages = "264--275",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of adrenomedullin, a hypotensive peptide, in the trophoblast giant cells at the embryo implantation site in mouse

AU - Yotsumoto, Shinichi

AU - Shimada, Tokihiko

AU - Cui, Chang Yi

AU - Nakashima, Hiroshi

AU - Fujiwara, Hiroyuki

AU - Ko, Minoru

PY - 1998/11/15

Y1 - 1998/11/15

N2 - Adrenomedullin (AM) is a newly discovered hypotensive peptide which is believed to play an important role for blood pressure control in the adult. Although it has been well established that a major production site of AM is vascular endothelial cells, we now show that AM is most highly expressed in trophoblast giant cells, which are derived from the conceptus and are directly in contact with maternal tissues at the implantation site. Northern blot and in situ hybridization analyses show that the AM mRNA begins to be detected just after implantation and its level peaks at 9.5 days postconception (d.p.c.) in those cells. Expression then falls dramatically after 10.5 d.p.c., coincident with the completion of the mature chorioallantoic placenta. Immunohistochemical analyses show that the AM peptide is secreted from the trophoblast giant cells into the surrounding tissues, i.e., embryo, decidua, and maternal circulation. In contrast, the expression of an AM receptor was not detected by Northern blot analyses in either embryo or trophoblast giant cells at 7 d.p.c., when the AM gene is most highly expressed in the trophoblast giant cells. This suggests that the AM produced and secreted from the embryo's trophoblast giant cells acts on the maternal tissues rather than on the embryonic tissues. Based on these results, we propose that the high production of AM may be the mechanism by which the embryos survive at the early postimplantation period by pooling maternal blood in the implantation site in order to secure nutrition and oxygen before the establishment of efficient embryo-maternal circulation through the mature placenta.

AB - Adrenomedullin (AM) is a newly discovered hypotensive peptide which is believed to play an important role for blood pressure control in the adult. Although it has been well established that a major production site of AM is vascular endothelial cells, we now show that AM is most highly expressed in trophoblast giant cells, which are derived from the conceptus and are directly in contact with maternal tissues at the implantation site. Northern blot and in situ hybridization analyses show that the AM mRNA begins to be detected just after implantation and its level peaks at 9.5 days postconception (d.p.c.) in those cells. Expression then falls dramatically after 10.5 d.p.c., coincident with the completion of the mature chorioallantoic placenta. Immunohistochemical analyses show that the AM peptide is secreted from the trophoblast giant cells into the surrounding tissues, i.e., embryo, decidua, and maternal circulation. In contrast, the expression of an AM receptor was not detected by Northern blot analyses in either embryo or trophoblast giant cells at 7 d.p.c., when the AM gene is most highly expressed in the trophoblast giant cells. This suggests that the AM produced and secreted from the embryo's trophoblast giant cells acts on the maternal tissues rather than on the embryonic tissues. Based on these results, we propose that the high production of AM may be the mechanism by which the embryos survive at the early postimplantation period by pooling maternal blood in the implantation site in order to secure nutrition and oxygen before the establishment of efficient embryo-maternal circulation through the mature placenta.

KW - Adrenomedullin

KW - Gene expression

KW - Implantation

KW - Mouse

KW - Trophoblast giant cells

UR - http://www.scopus.com/inward/record.url?scp=0032533301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032533301&partnerID=8YFLogxK

U2 - 10.1006/dbio.1998.9073

DO - 10.1006/dbio.1998.9073

M3 - Article

VL - 203

SP - 264

EP - 275

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 2

ER -